The sprint to solve coronavirus protein structures — and disarm them with drugs
nature.com · 638 words · saved by 1 readers
Stopping the pandemic could rely on breakneck efforts to visualize SARS-CoV-2 proteins and use them to design drugs and vaccines.
Email Bluesky Facebook LinkedIn Reddit Whatsapp X Credit: Cognition Studio Inc. Access through your institution Buy or subscribe Lying in bed on the night of 10 January, scrolling through news on his smartphone, Andrew Mesecar got an alert. He sat up. It was here. The complete genome of a coronavirus causing a cluster of pneumonia-like cases in Wuhan, China, had just been posted online. Access options Access through your institution Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Learn more Subscribe t
related reading
- Protein World Model | Biohubbiohub.ai
- AlphaProteo generates novel proteins for biology and health researchdeepmind.google
- What We Learned Doing Fast Grants | Futurefuture.a16z.com
- AlphaFolddeepmind.google
- Coronavirus envelope protein - Wikipediaen.wikipedia.org
- One-shot design of functional protein binders with BindCraftnature.com
- An Open Letter in Support of Mandatory Nucleic Acid Synthesis Screening and Recordkeepingscreendna.org
- OpenBio - Cursor for Biology | AI-Powered Research Platformopenbio.tech
- AlphaFold: a solution to a 50-year-old grand challenge in biologydeepmind.com
- Claude Science (beta) | Claude by Anthropicclaude.com
- The trinity of COVID-19: immunity, inflammation and interventionnature.com
- Why were Covid vaccine trials so fast?substack.com